148 related articles for article (PubMed ID: 2501615)
1. The new teratogens: accutane and other vitamin-A analogs.
Thomson EJ; Cordero JF
MCN Am J Matern Child Nurs; 1989; 14(4):244-8. PubMed ID: 2501615
[No Abstract] [Full Text] [Related]
2. Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program.
Brinker A; Kornegay C; Nourjah P
Arch Dermatol; 2005 May; 141(5):563-9. PubMed ID: 15897377
[TBL] [Abstract][Full Text] [Related]
3. Oral retinoids. What should the prescriber known about their teratogenic hazards among women of child-bearing potential?
Mitchell AA
Drug Saf; 1992; 7(2):79-85. PubMed ID: 1605903
[No Abstract] [Full Text] [Related]
4. Teratogen update: vitamin A congeners.
Rosa FW; Wilk AL; Kelsey FO
Teratology; 1986 Jun; 33(3):355-64. PubMed ID: 3461576
[TBL] [Abstract][Full Text] [Related]
5. [Accutane (isotretinoic acid)--a new human teratogen].
Kucera J
Cesk Gynekol; 1985 Jul; 50(6):418-9. PubMed ID: 3861266
[No Abstract] [Full Text] [Related]
6. Multiple temporal bone anomalies in isotretinoin syndrome: a temporal bone histopathologic case report.
Ishijima K; Sando I
Arch Otolaryngol Head Neck Surg; 1999 Dec; 125(12):1385-8. PubMed ID: 10604421
[TBL] [Abstract][Full Text] [Related]
7. Major auricular malformations due to Accutane (isotretinoin).
Jahn AF; Ganti K
Laryngoscope; 1987 Jul; 97(7 Pt 1):832-5. PubMed ID: 2955181
[TBL] [Abstract][Full Text] [Related]
8. Safety of pregnancy after discontinuation of isotretinoin.
Dai WS; Hsu MA; Itri LM
Arch Dermatol; 1989 Mar; 125(3):362-5. PubMed ID: 2923442
[TBL] [Abstract][Full Text] [Related]
9. Restriction of the use of drugs with teratogenic properties: Swedish experiences with isotretinoin.
Källén B
Teratology; 1999 Aug; 60(2):53. PubMed ID: 10440771
[No Abstract] [Full Text] [Related]
10. How to ensure fetal safety when mothers use isotretinoin (Accutane).
Koren G; Pastuszak A
Can Fam Physician; 1997 Feb; 43():216-9. PubMed ID: 9040906
[No Abstract] [Full Text] [Related]
11. Continued occurrence of Accutane-exposed pregnancies.
Honein MA; Paulozzi LJ; Erickson JD
Teratology; 2001 Sep; 64(3):142-7. PubMed ID: 11514944
[TBL] [Abstract][Full Text] [Related]
12. Accutane-induced teratogenesis.
Robertson R; MacLeod PM
CMAJ; 1985 Dec; 133(11):1147-8. PubMed ID: 2933136
[No Abstract] [Full Text] [Related]
13. Teratogenicity of systemic isotretinoin.
Holst H; Muhari-Stark E; Lava SA
Minerva Pediatr; 2018 Feb; 70(1):107-109. PubMed ID: 29363297
[No Abstract] [Full Text] [Related]
14. The power of Accutane. The benefits and risks of a breakthrough acne drug.
Meadows M
FDA Consum; 2001; 35(2):18-23. PubMed ID: 11444244
[No Abstract] [Full Text] [Related]
15. Pledging for accutane.
Healy B
US News World Rep; 2005 Sep; 139(8):63. PubMed ID: 16159042
[No Abstract] [Full Text] [Related]
16. Potential subversion of pregnancy prevention program in the managed care setting.
Wilkin JK
Arch Dermatol; 1997 Feb; 133(2):243-4. PubMed ID: 9041846
[No Abstract] [Full Text] [Related]
17. Birth defects caused by isotretinoin--New Jersey.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1988 Mar; 37(11):171-2, 177. PubMed ID: 3126387
[No Abstract] [Full Text] [Related]
18. [Accutane--a new human teratogen as a cause of a new syndrome].
Kucera J
Cesk Pediatr; 1985 Jun; 40(6):358. PubMed ID: 3860303
[No Abstract] [Full Text] [Related]
19. [Teratogenic risks of high-dosage vitamin A].
Knijn GJ; Cornel MC; de Jong-van den Berg LT; de Smet PA
Ned Tijdschr Geneeskd; 1992 Oct; 136(42):2060-5. PubMed ID: 1407207
[No Abstract] [Full Text] [Related]
20. Contraceptive efficacy.
Trussell J
Arch Dermatol; 1995 Sep; 131(9):1064-8. PubMed ID: 7661610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
